Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5571_Библиотеки_им_академика_М_И_Перельмана
.pdf
TABLE 2.11 Free Chemistry Databases
Database URL Reference
ACToR http://actor.epa.gov/actor/faces/ACToRHome.jsp [220]
AKos http://www.akosgmbh.de/AKosSamples/index.html [221]
Allergen Atlas http://tiger.dbs.nus.edu.sg/ATLAS/ [222]
Animal Toxin
Database
http://protchem.hunnu.edu.cn/toxin/index.jsp [223]
Brenda http://www.brenda-enzymes.info/ [224]
Biometa http://biometa.cmbi.ru.nl/ [225]
ChEBI http://www.ebi.ac.uk/chebi/ [226]
ChemBank http://chembank.broad.harvard.edu/ [227]
ChemSpider http://www.chemspider.com [228]
Clan Tox http://www.clantox.cs.huji.ac.il/ [229]
Ditop http://bioinf.xmu.edu.cn/databases/ADR/index.html [230]
DSSTox http://www.epa.gov/ncct/dsstox/index.html [231]
DrugBank http://www.drugbank.ca/ [232]
DUD http://dud.docking.org/ [233]
eMolecules http://www.emolecules.com/ [234]
EMBL Databases http://www.ebi.ac.uk/FTP/ [235]
HaptenDB http://www.imtech.res.in/raghava/haptendb/ [236]
Human
Metabolome
Database
http://www.hmdb.ca/ [237]
KEGG Drug http://www.genome.jp/kegg/drug/ [238]
KEGG Ligand http://www.genome.jp/kegg/ligand.html [238]
Ligand Expo http://ligand-expo.rcsb.org/ [239]
LigandInfo http://www.ligand.info/ [240]
MDPI http://www.mdpi.org/molmall/ [241]
Metabolic Site
Predictor
http://www-ucc.ch.cam.ac.uk/msp/htdocs/ [242]
MMsINC http://mms.dsfarm.unipd.it/MMsINC.html [243]
MDSI http://www.msdiscovery.com/downloads.html [244]
US NCI Database http://cactus.nci.nih.gov/ncidb2/download.html [245]
US National
Toxicology
Program
http://ntp.niehs.nih.gov/ [246]
PubChem http://pubchem.ncbi.nlm.nih.gov/ [247]
Querychem http://llama.med.harvard.edu/jklekota/QueryChem.html [248]
Relibase http://www.ccdc.cam.ac.uk/free_services/free_downloads/ [249]
Screening Browser http://cimlcsext.cim.sld.cu:8080/screeningbrowser [250]
SuperNatural
Database
http://bioinformatics.charite.de/supernatural [251]
SuperDrug http://bioinf.charite.de/superdrug/ [252]
SuperHapten http://bioinformatics.charite.de/superhapten/ [253]
SuperLigands http://bioinformatics.charite.de/superligands/ [254]
SuperToxic http://bioinformatics.charite.de/supertoxic [255]
TimTec http://www.timtec.net/ [256]
78
IN SILICO ADME/Tox PREDICTIONS
https://t.me/medicina_free

PubChem continues to grow in stature, content, and capability and will take a
prominent role in the field of chemical biology and drug discovery.
ZINC ZINC (http://zinc.docking.org/) [261] is a free database of commercially
available compounds ready for virtual screening computations. The library contains
over 8 million molecules in 3D, most often annotated with molecular properties.
ZINC allows a user to create a subset based on physicochemical properties and is
TABLE 2.11 (Continued )
Database URL Reference
TOXNET http://toxnet.nlm.nih.gov [257]
Toxicity Datasets http://cheminformatics.org/datasets/index.shtml#tox [258]
UCI ChemDB http://cdb.ics.uci.edu/ [259]
VITIC http://www.lhasalimited.org/index.php?cat¼2&sub_cat¼72 [260]
ZINC http://zinc.docking.org/ [261]
TABLE 2.12 Commercial Databases and Compound Libraries
Database URL
4SC http://www.4sc.de
ACB blocks http://www.acbblocks.com
Akos http://www.akosgmbh.com
Ambinter http://www.ambinter.com/
AnalytiCon discovery http://www.ac-discovery.com
Arkive http://ark.chem.ufl.edu/pages/arkive.htm
Array BioPharma http://www.arraybiopharma.com
Asinex http://www.asinex.com
Aurora http://www.aurora-feinchemie.com
BioFocus http://www.biofocus.com/
CEREP http://www.cerep.fr/Cerep/Users/index.asp
ChemBridge http://www.chembridge.com/
Chemical Diversity http://www.chemdiv.com/
Chemical Block http://www.chemical-block.com
Combi-Blocks http://www.combi-blocks.com/
Comprehensive
Medicinal Chemistry
http://www.symyx.com/products/databases/bioactivity/
cmc/index.jsp
ChemStar http://www.chemstar.ru
ComGenex http://www.rdchemicals.com/targeted-compound-libraries/
comgenex.html
EMC http://www.microcollections.de/
Enamine http://www.enamine.relc.com
IFLab http://www.iflab.kiev.ua
InterBioScreen http://www.ibscreen.com
iResearch Library http://www.chemnavigator.com/cnc/products/IRL.asp
(Continued )
PREPARATION OF COMPOUND COLLECTIONS AND COMPUTER PROGRAMS 79
https://t.me/medicina_free

target-dependent. ZINC is provided by the Shoichet Lab, in the Department of
Pharmaceutical Chemistry at the University of California, San Francisco (UCSF).
2.3.2.3 Free Tools to Filter Compound Libraries
Standalone Versions
(a) FAF-Drugs2
http://www.mti.univ-paris-diderot.fr/fr/downloads.html
FAF-Drugs2 [262] is a free adaptable tool for the ADME/Tox filtering of
electronic compound collections. FAF-Drugs2 is a command-line utility
program (e.g., written in Python) based on the open source chemistry toolkit
OpenBabel. FAF-Drugs2 performs various physicochemical calculations,
identifies key functional groups such as some toxic and unstable molecules/
functional groups, and can provide, via Gnuplot, several distribution diagrams
of major physicochemical properties of the screened libraries. Within FAFDrugs2, numerous physicochemical and substructure searching filtering rules
can be easily tuned, depending on the projects and aims.
TABLE 2.12 (Continued )
Database URL
Key organics Ltd http://www.keyorganics.ltd.uk
Leadscope http://www.leadscope.com/
Maybridge http://www.maybridge.com
MDDR http://www.symyx.com/products/databases/bioactivity/
mddr/index.jsp
MDPI http://www.mdpi.org/molmall/
MDL ACD http://www.symyx.com/
MSDiscovery http://www.msdiscovery.com
Nanosyn http://www.nanosyn.com
Pharmacopeia http://www.pharmacopeia.com/
Pharmeks http://www.pharmeks.com
Polyphor http://www.polyphor.com/
Prestwick http://www.prestwickchemical.com
StARLITe http://www.admensa.com/StARLITe/Index.htm
Sigma-Aldrich http://www.sigma-aldrich.com
Specs http://www.specs.net
SPRESI http://infochem.de/en/products/databases/spresi.shtml
TimTec http://www.timtec.net
TOSLab http://www.toslab.com
Tranzyme http://www.tranzyme.com/
Tripos http://leadquest.tripos.com
VitasMLab http://www.vitasmlab.com/
WOMBAT http://www.sunsetmolecular.com/index.php
Worldmolecules http://www.worldmolecules.com/
Commercial Databases and Compound Libraries (Continued )
80
IN SILICO ADME/Tox PREDICTIONS
https://t.me/medicina_free

(b) CLEVER
http://datam.i2r.a-star.edu.sg/clever/
CLEVER [263] (Chemical Library Editing, Visualizing and Enumerating
Resource) is a free platform- independent, standalone Java application. It
supports chemical library creation and manipulation, combinatorial chemical
library enumeration using user-specified chemical components, and chemical
format conversion and visualization. CLEVER analyses and filters compound
libraries with respect to drug-likeness, lead-likeness, and fragment-likeness
based on computed physicochemical properties.
(c) Screening-Assistant
http://www.univ-orleans.fr/icoa/screeningassistant/
Screening-assistant [118] is designed to manage chemical databases and
select a set of compounds for screening tests. Drug-like properties are
computed and molecules that are predicted to be nondrug-like are highlighted.
(d) ToxTree
http://ecb.jrc.ec.europa.eu/qsar/qsar-tools/index.php?c¼TOXTREE
ToxTree [264] is a free application developed by Ideaconsult Ltd. The
program can categorize and predict various kinds of toxic effects by applying
decision tree approaches, such as the Cramer [265] classification scheme for
skin and eye irritation, and the Benigni–Bossa rule based models [29] for
mutagenicity and carcinogenicity.
(e) sMol Explorer
http://www.biotec.or.th/ISL/SMOL/
sMOL Explorer [266] is a web-based open source integrated suite that
provides necessary tools for chemists to design and mine a compound library
either by drawing molecules or uploading (query) data files. The user’s database
created by the software can be analyzed, structural similarity search can be
performed, and results can be compared to existing external public databases,
such as PubChem and DrugBank. Users can mine the database with programming language R (designed for statistical computing) and Weka software (Java
written toolkit of machine learning algorithms designed for data mining). The
packages are included inside sMol Explorer with the aim of finding frequent
substructures, cluster compounds using molecular fingerprints, and defining a
classification model compatible with a desired biological activity.
(f) XLOGP3
http://www.sioc-ccbg.ac.cn/software/xlogp3/
This toolkit provides functionalities to screen a compound library including
log P computation [267]. XLOGP3 can remove compounds that do not satisfy
“drug-likeness” properties such as Lipinski’s RO5, number of rotatable bonds,
and number of rings.
Online Tools>
(a) VCCLAB Servers
http://vcclab.org/lab/alogps/
PREPARATION OF COMPOUND COLLECTIONS AND COMPUTER PROGRAMS 81
https://t.me/medicina_free

VCCLAB [86] provides several on-line tools, which are able to compute log
P, log S,pK
a
, and more than 1600 molecular descriptors from the DRAGON
software. These tools can be useful for computational chemistry, ADME/Tox
predictions via the calculation of molecular properties, and the analysis of
relationships between chemical structure and properties.
(b) ChemMine
http://bioweb.ucr.edu/ChemMineV2/
ChemMine [268] is a compound mining database that facilitates drug and
agrochemical discovery and chemical genomics screens.
(c) ChemXSeer
http://chemxseer.ist.psu.edu/
ChemXSeer [269] is an integrated digital library and database allowing for
intelligent search of documents in the field of chemistry and data obtained
from chemical kinetics.
(d) Chemaxon
http://www.chemaxon.com/
Through the company website, Chemaxon provides several online toolkits
pertaining to the field of chemoinformatics and allowing compound profiling.
(e) eMolecules
http://www.emolecules.com/
eMolecules is a free online database and perhaps the most comprehensive
openly accessible search engine for chemical structures. eMolecules offer over
7 million unique chemical structures supplied by over 150 suppliers.
(f) Lazar Toxicity Predictions
http://lazar.in-silico.de/
The Lazar [270] system allows to predict some aspects of toxicity. It is
possible to draw a query compound and perform a similarity search across
compounds with experimentally determined toxicity data.
(g) Molinspiration
http://www.molinspiration.com/
Molinspiration is an online molecular processing and property calculation
toolkit that allows users to analyze chemical compounds.
(h) MolSoft
http://www.molsoft.com/mprop/
MolSoft is an online drug-likeness and molecular property prediction
toolkit.
(i) OSIRIS
http://www.organic-chemistry.org/prog/peo/index.html
OSIRIS [271] allows users to draw a molecule and compute instantly various
drug-relevant properties, high risks for undesired effects such as mutagenicity,
or a poor intestinal absorption.
(j) PK/DB
http://miro.ifsc.usp.br/pkdb/
82 IN SILICO ADME/Tox PREDICTIONS
https://t.me/medicina_free

PK/DB [272] is a free database for pharmacokinetic properties designed to
create online databases for pharmacokinetic studies and in silico ADME/Tox
prediction.
(k) RoadRunner
http://nmmlsc.health.unm.edu/rrnmmlsc/
Roadrunner is a free online access of properties and bioactivities to over
220,000 unique compounds, which allows user compound searches by
similarity or to obtain experimental assays related to the compound of interest.
(l) RPBS
http://bioserv.rpbs.jussieu.fr
RPBS [273] (Ressource Parisienne en Bioinformatique Structurale) is a web
server that provides several tools for database preparation, test sets for virtual
ligand screening and basic ADME/Toxfiltering via FAFDrugs1 online version,
salts removal, file format conversion, or compound collections in 3D. Online
ligand-based methods are available and searches against libraries of toxic
molecules and drug-like compounds using wwLigCSRre can be
performed [274].
(m) SuperDrug
http://bioinformatics.charite.de/superdrug/
SuperDrug [252] allows user to access 2396 compounds with 108,198
conformers and manage 2D similarity searching.
(n) XLOGP3
http://www.sioc-ccbg.ac.cn/software/xlogp3/
XLOGP3 [267] software can also be accessible online and can predict basic
drug-likeness chemical rules.
(o) ISIDA
http://infochim.u-strasbg.fr/recherche/isida/index.php
ISIDA In Silico Design and Data Analysis is a project devoted to the
development of new methods and original soft ware tools for structure–property modeling and computer-aided design of new compounds, from ligand
screening to ADME/ Tox predictions [275].
Commercial Packages Table 2.13 presents a list of commercial software packages
to predict ADMET properties.
2.3.3 Cleaning and Designing the Compound Collection
It is beneficial to process and filter a compound library in order to retain as much as
possible “lead-like” or “drug-like” compounds and reject undesirable molecules.
Several commercial packages have been developed to perform collection filtering
(e.g., ChemAxon [287], OpenEye [279], or the Chemical Computing Group [286]).
These filter-based approaches should not be used as “black-boxes.” In general, users
have to “clean-up” the collection by first removing salts/counterions and duplicates
from the library. The compound library must be in a computer-acceptable standard
PREPARATION OF COMPOUND COLLECTIONS AND COMPUTER PROGRAMS 83
https://t.me/medicina_free

format (e.g., user must check for wrong entries, bad connection tables, incorrect chiral
centers, etc.). Cleaning and filtering the database can also be performed at a later
stage, for example, after a first in silico screening step. Overall, users must note that
compound physicochemical properties have to be considered before preparing a
collection and take into account
.
the biological nature/typ e of the target,
.
the anatomic region and the disease/pathology to treat, and
.
the administration route.
One can apply both simple rules such as the Lipinski’s “rule-of-5” [210], as well as
additional filters that assess the presence of functional groups known to be toxic or
TABLE 2.13 Commercial Software Packages to Predict ADMET Properties
Software Description Predictions References
DEREK Knowledge-based systems C
c,Mm,Gg,Ss
,
T
tt,Hh,Nn
[276]
METEOR Mt
mt
www.lhasalimited.org
META/MCASE/CASETOX Knowledge-based systems Mt/C/A
a
/C/M [277]
www.multicase.com
ADMENSA Interactive Proprietary ToolBox A [278]
www.admensa.com
OpenEye Filter Proprietary ToolBox A [279]
www.eyesopen.com
Schr€odinger QikProp Proprietary ToolBox A [280]
https://www.schrodinger.com
Discovery Studio 2.0 Proprietary ToolBox [281]
www.accelrys.com
ADMET Descriptors Knowledge-based system A/H
TOPKAT QSAR-based system C/M/S/A
VolSurf þ Molecular descriptors D
d
/A [282]
MokA Statistical model for
pK
a
predictions
[283]
http://www.moldiscovery.com/
index.php
OncoLogic Knowledge-based system C [284]
Quantum Pharmaceutical Suite Knowledge-based system A/D [285]
http://q-pharm.com
MOE Proprietary Toolbox A/D [286]
http://www.chemcomp.com Molecular Descriptors
OncoLogic Knowledge-based system C [284]
a
ADME/Tox optimization,dDMPK,cCarcinogenicity,mMutagenicity,gGenotoxicity,sSkin Sensitisation,
tt
Teratogenicity,hHepatotoxicity,nNeurotoxicity,mfMetabolism fate.
84 IN SILICO ADME/Tox PREDICTIONS
https://t.me/medicina_free

that are reactive or unstable. Many such rules have been proposed [211, 212, 214] in
the past few years. Problematic structure or groups can be specified by using
SMARTS[218] pattern matching. Such an approach has been exploited at Bayer [120]
by tagging molecules that contain specific fragments. Possible values for some
descriptors to generate a drug-like collection could be as follows:
.
no more than one violation of RO5 (200 MW 500, log P 5, HBD 5,
HBA 10).
.
tPSA no more than 160
.
no more than 10 rotatable bonds
.
no more than 50 rigid bonds
.
no more than four ring system
.
no more than 35 heavy atoms
.
no more 20 atoms in a system ring
.
no more than 35 carbon atoms
.
no more than 20 heteroatoms
.
formal charge within 0–3
.
sum of formal charges within 2to2
.
eliminate compounds having undesirable atom types and unacceptable functional groups (Figure 2.25).
2.3.4 Searching for Similarity
Medicinal chemists usually assume that similar compounds are likely to have similar
properties. Subsequently, it is interesting to compare compounds present in a
collection and marketed, active, experimental molecules as well as to withdrawn
drugs or even natural products. For this purpose, numerous approaches could be
employed [104] depending on the choice of molecular descriptors, weighting
procedure(s), and similarity coefficient (e.g., Tanimoto) [104]. In addition, several
recognition methods of specific frameworks designed for similarity (dissimilarity)
measures are also available [17, 111, 120, 288–290].
Figure 2.25 Examples of functional groups known to be reactive or toxic [215].
PREPARATION OF COMPOUND COLLECTIONS AND COMPUTER PROGRAMS 85
https://t.me/medicina_free

2.3.5 Generating 3D Structures
In silico screening methods based on ligand 3D structures (ligand-based screening
computations or structure-based screening methods) have become essential tools to
facilitate the drug discovery process. The structure of each ligand has to be generated
since compounds are usually distributedin 2D fileformat. Some descriptors involved in
several ADME/Tox prediction models also require the 3D structures of the molecules.
The user has the choice between free toolkits or commercial packages. For the latter,
Molecular Networks CORINA, Tripos CONCORD
, or OpenEye OMEGA are cited.
Severalfreestandaloneoronlinetoolsarealsoavailable.Balloon [291] (http://users.abo.
fi/mivainio/balloon/), smi2sdf (http://www.chembiogrid.org/cheminfo/smi23d/#ack),
The Dundee PRODRG2 Server [292] (http://davapc1.bioch.dundee.ac.uk/prodrg/),
FROG [293] (http://bioserv.rpbs.jussieu.fr/cgi-bin/Frog), and DG-AMMOS (http://
www.vls3d.com/DGAMMOS/DG-AMMOS.tar.gz) are cited.
2.4 ADME/Tox PREDICTIONS WITHIN PHARMACEUTICS
COMPANIES
Below is the list of different types of in silico filtering tools pharmaceutical companies
have used to process their compound collections.
2.4.1 Actelion Pharmaceuticals Ltd.
Actelion uses chemoinformatics strategies as opposed to conventional approaches
(use of expensive commercial packages) since they implemented their own internal
system. Actelion developed the OSIRIS procedure [271] and implemented a toxicity
alert system.
2.4.2 Bayer
At Bayer HealthCare Pharma, chemoinformatics tools and in silico ADME/Tox
predictions are usually used in the early hit discovery phase and during the hit-to-lead
optimization steps [123, 294]. These techniques are employed just after the screening
hits have been validated and prior to in vitro and in vivo characterization. Bayer has
developed an in-house system to flag compounds, named TLs for “traffic lights” and
where different values are summed to derive an in silico oral PhysChem score ranging
from 0 to 10. The lower the values, the more the compounds are suitable for oral
administration. The traffic lights involve TL Microsomal Clearance Alert, TL CYP
Inh Alert, TL hERG Inh Alert, TL Undesirable Groups, the PhysChem score derived
from the values of TL Solubility score (50, 10–50, 10), TL C log P (3, 3–5, 5),
TL MWcorr (400, 400–500, 500), TL PSA (120, 120–140, 140), TL RotBonds
(7, 8–10, 11), and the TL Caco-2 score built from a decision tree that involves
H-bond acidity and basicity, PSA, MW, and charges. Bayer has recently developed
CypScore [295], an in silico tool able to predict the likely sites of cytochrome
P450-mediated metabolism of drug-like organic molecules.
86 IN SILICO ADME/Tox PREDICTIONS
https://t.me/medicina_free

2.4.3 Bristol-Myers Squibb
Data collected during the HTS process are stored and analyzed. The company applies
empirical methods to help validate the filter tool. According to Pearce et al. [296],
Bristol-Myers Squibb applies Lipinski-type propert y filters as part of an HTS triage
carried out at a later stage rather than at the beginning of the screening process. During
the filtering step, a compound is flagged if it has two or more violations over these
following values, MW > 639, the number of hydrogen bond donors >5, the number of
hydrogen bond acceptors > 9, the number of rotata ble bonds > 14, and the C log P is
between 3.0 and 5.5. Earlier in the HTS process, an in- house SMARTS-based
chemical functional groups filtering process intended for compound removal is
applied. The Promiscuity Ratio Index (PRI), an observed/expected functional group
filter hit rate, and the Promiscuity Strength Index (PSI), the strength of that hit rate
across multiple assays, are measured. These were combined with a statistical analysis
of in-house assay data to provide confidence intervals that link the filters to a
promiscuity category (high, medium, and low).
2.4.4 Hoffmann-La Roche Ltd.
At Roche, computer-assisted methods are directly integrated in the medicinal
chemistry department and their use is defined by the screening strategy [31, 297].
A proprietary filtering procedure based on lead generation divided into four phases—
hit evaluation, hit validation, lead generation, and lead expansion—is used [298].
ADME/Tox is performed early during hit evaluation and validation involving the
selection of compounds with suitable physicochemical properties according to the
common “desirable” substructures and/or u ndesired structural features employing
commercial tools. The company also developed proprietary in silico tools—CAFCA
and RADDAR [298, 299]. The former was for the calculation of molecule’s
amphiphilic properties and the latter for the design of virtual libraries. Using the
commercial software Leadscope, a computer-based method [214] for rapid and
automatic identification of potential “frequent hitters” (compounds with nonspecific
activity, promiscuous) or that are disturbing the assays was developed.
2.4.5 Neurogen Corporation
At Neurogen, an internal analysis [122] on oral drugs launched from 1984 to 2002
suggested that physicochemical ranges could be scaled according to Lipinski RO5
and demonstrated that some physicochemical properties were increasing during the
optimization phase. To improve the success, an in-house virtual library, named
PriVLib (Privileged Virtual Library), was developed. PriVLib has several desirable
properties including low molecular weight, low lipophilicity, relatively high solubility, and high likelihood of synthetic success and immediate availability of
synthesis. To share and to standardize internal information in the aim to help in the
design of drugs, a proprietary chemoinformatic language, NDL (Neurogen Data
Language), which is coupled to a web-based data display system, was developed.
ADME/Tox PREDICTIONS WITHIN PHARMACEUTICS COMPANIES 87
https://t.me/medicina_free
Соседние файлы в папке Библиотека им академика М.И. Перельмана
